Parallel Advisors, LLC Blueprint Medicines Corp Transaction History

Parallel Advisors, LLC

  • $4.18 Billion
  • Q3 2024

A detailed history of Parallel Advisors, LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Parallel Advisors, LLC holds 286 shares of BPMC stock, worth $26,203. This represents 0.0% of its overall portfolio holdings.

Number of Shares
286
Previous 259 10.42%
Holding current value
$26,203
Previous $27,000 3.7%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$84.1 - $120.5 $2,270 - $3,253
27 Added 10.42%
286 $26,000
Q2 2024

Aug 08, 2024
SELL
$85.18 - $108.78 $1,448 - $1,849
-17 Reduced 6.16%
259 $27,000
Q1 2024

May 06, 2024
BUY
$73.17 - $99.79 $2,048 - $2,794
28 Added 11.29%
276 $26,000
Q4 2023

Feb 09, 2024
BUY
$43.96 - $92.84 $5,187 - $10,955
118 Added 90.77%
248 $22,000
Q3 2023

May 20, 2024
BUY
$46.9 - $66.0 $5,674 - $7,986
121 Added 1344.44%
130 $6,000
Q3 2023

Nov 13, 2023
BUY
$46.9 - $66.0 $5,674 - $7,986
121 Added 1344.44%
130 $6,000
Q1 2023

May 20, 2024
SELL
$37.97 - $50.0 $10,137 - $13,350
-267 Reduced 96.74%
9 $0
Q1 2023

Apr 25, 2023
BUY
$37.97 - $50.0 $341 - $450
9 New
9 $0
Q3 2022

Nov 10, 2022
BUY
$49.93 - $77.7 $299 - $466
6 New
6 $0
Q2 2022

Aug 01, 2022
SELL
$45.23 - $70.15 $949 - $1,473
-21 Closed
0 $0
Q1 2022

Apr 28, 2022
SELL
$54.1 - $110.08 $6,870 - $13,980
-127 Reduced 85.81%
21 $1,000
Q4 2021

Jan 20, 2022
SELL
$94.25 - $115.99 $188 - $231
-2 Reduced 1.33%
148 $16,000
Q3 2021

Nov 02, 2021
BUY
$80.98 - $109.47 $10,446 - $14,121
129 Added 614.29%
150 $15,000
Q2 2021

Aug 06, 2021
SELL
$82.78 - $101.0 $910 - $1,111
-11 Reduced 34.38%
21 $2,000
Q1 2021

Apr 23, 2021
BUY
$90.71 - $108.28 $997 - $1,191
11 Added 52.38%
32 $3,000
Q2 2020

Jul 16, 2020
SELL
$57.09 - $79.27 $742 - $1,030
-13 Reduced 38.24%
21 $1,000
Q1 2020

Apr 27, 2020
BUY
$48.11 - $82.22 $577 - $986
12 Added 54.55%
34 $1,000
Q2 2019

Aug 05, 2019
BUY
$73.54 - $97.8 $1,617 - $2,151
22 New
22 $2,000
Q3 2018

Nov 01, 2018
SELL
$58.91 - $78.32 $942 - $1,253
-16 Closed
0 $0
Q2 2018

Jul 30, 2018
BUY
$60.96 - $101.18 $975 - $1,618
16 New
16 $1,000

Others Institutions Holding BPMC

# of Institutions
351
Shares Held
60.3M
Call Options Held
2.25M
Put Options Held
1.18M
View Full List

About Blueprint Medicines Corp

BPMC Quotes by TradingView
  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.47B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Parallel Advisors, LLC Portfolio

Follow Parallel Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallel Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Parallel Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email